A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster

J Antimicrob Chemother. 1995 Jul;36(1):271-3. doi: 10.1093/jac/36.1.271.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Acyclovir / adverse effects*
  • Acyclovir / pharmacokinetics*
  • Acyclovir / therapeutic use
  • Aged
  • Aged, 80 and over
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / pharmacokinetics*
  • Antiviral Agents / therapeutic use
  • Female
  • Herpes Zoster / drug therapy
  • Herpes Zoster / metabolism*
  • Humans
  • Male
  • Middle Aged

Substances

  • Antiviral Agents
  • Acyclovir